Hatchtech appoints Tim Waugh as ceo

Formerly with Roche in the US as a divisional vice president

Australian pharmaceutical firm Hatchtech has appointment Timothy Waugh as chief executive.

Waugh has worked in the pharmaceutical industry for 27 years and has spent the last 10 years with Roche in the US as a divisional vice president.

Paul Kelly, Hatchtech’s chairman, said: ‘Tim’s skill set and extensive experience will be a strong addition and complement those existing in the company. The Board is confident this management team will serve us well as we take the company into the next stage of developing and commercialising DeOvo for the global marketplace.’

DeOvo is a topical formulation of a known metalloprotease inhibitor and offer the potential for a head lice control treatment that requires only one application.

Waugh said he looks forward to working with Hatchtech’s Board and management team as it review the results of the Phase IIb study and plan for the next stages of its clinical development.

Waugh will join the Board of Hatchtech and will be based in New Jersey, US.

You may also like

Marketing

Indena to highlight expanded HPAPI, ADC and peptide drug conjugate capabilities at DCAT Week 2026

Italian CDMO Indena will showcase its high-potency API manufacturing expertise and growing oncology-focused capabilities at DCAT Week in New York, including ten commercial HPAPIs in production and advancing work in antibody-drug and peptide drug conjugates
Regulatory

MHRA gives guidance to phase out animal testing

The UK regulatory body is aiming to replace animal usage in science by backing developers using non-animal methods and offering early data reviews
Manufacturing

Wilmington PharmaTech invests $50m into US small-molecule API manufacturing plant

The CRDMO will more than double the capacity in its current API reactor in Delaware, positioning itself to meet growing demand for US-based manufacturing
Manufacturing

L.B. Bohle at Interphex 2026

Continuous manufacturing and tablet processing technologies
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Sealing confidence: how Torbay Pharma ensures sterile precision from fill to finish

Torbay Pharma combines reliable crimp capping and precision pump technologies to maintain the sterile integrity, accurate dosing and uninterrupted supply of critical injectable medicines
Manufacturing

New agitator platform from Alfa Laval: A milestone breakthrough in effortless mixing in hygienic production

Delivering massive energy savings, easy maintenance – and prepared for industrial connectivity, the new EnSaLineTM agitators from Alfa Laval set a new standard for exceptional agitator performance
Manufacturing

Reliable detection for high-temperature processes

ifm has launched the LMH point level sensor, a robust solution engineered for reliable medium detection in demanding industrial environments
Subscribe now